The methodology disclosed herein compares favorably the state-of-the-art owing to its generality, robustness and versatility. In fact, it does not rely on any interaction between the ligated borane and the organic halide for the formation of the required C-centered radical and it is applicable to a vast array of substrates, including biologically active compounds. Further, continuous-flow technology can be exploited to accelerate and scale our methodology.